Phibro Animal Health (NASDAQ: PAHC) raises revolver to $435M
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Phibro Animal Health Corporation entered into Amendment No. 1 to its Credit Agreement with Coöperatieve Rabobank U.A. and other lenders on April 28, 2026. This amendment increases the company’s revolving credit commitment by $125,000,000, raising the facility from $310,000,000 to an aggregate commitment of $435,000,000.
The larger revolving credit line represents a new direct financial obligation for Phibro and is documented as a material definitive agreement. The full text of Amendment No. 1 is filed as Exhibit 10.1 and is incorporated by reference for detailed terms, representations and warranties.
Positive
- None.
Negative
- None.
Insights
Phibro expands revolving credit capacity by $125M, adding liquidity but also obligations.
Phibro Animal Health increased its revolving credit commitment from $310,000,000 to $435,000,000 under Amendment No. 1 to its Credit Agreement. A larger revolver typically provides more financing flexibility for working capital, acquisitions, or general corporate purposes, depending on how management uses it.
The filing also classifies this as a direct financial obligation, meaning borrowings under the expanded facility will sit on the balance sheet. Actual leverage effects will depend on future drawdowns and covenant terms described in the full amendment, which is attached as Exhibit 10.1.
8-K Event Classification
3 items: 1.01, 2.03, 9.01
3 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Revolver increase: $125,000,000
Previous revolver size: $310,000,000
New revolver size: $435,000,000
+1 more
4 metrics
Revolver increase
$125,000,000
Incremental revolving credit commitment under Amendment No. 1
Previous revolver size
$310,000,000
Revolving credit commitment under Original Credit Agreement
New revolver size
$435,000,000
Aggregate revolving credit commitment after Amendment No. 1
Exhibit 10.1
Amendment No. 1
Filed as material contract among Phibro, Rabobank and lenders
Key Terms
Material Definitive Agreement, revolving credit commitment, direct financial obligation, off-balance sheet arrangement, +2 more
6 terms
Material Definitive Agreement regulatory
"ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT."
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
revolving credit commitment financial
"the revolving credit commitment available to the Company under the Original Credit Agreement has increased"
A revolving credit commitment is a bank promise to lend up to a set amount that a company can borrow, repay, and borrow again as needed—similar to a business credit card with a fixed credit limit. It matters to investors because it provides flexible short-term cash when revenue fluctuates, reduces the risk of running out of funds, and influences a company’s borrowing costs and financial strength through interest, fees and any attached covenants.
direct financial obligation financial
"CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT"
off-balance sheet arrangement financial
"AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT."
An off-balance sheet arrangement is a financial commitment or asset that a company keeps out of its main financial statements so it does not show up as a direct asset or liability. Think of it like renting equipment or using a separate storage locker instead of putting the item in your home: the economic effects exist, but they aren’t listed on the company’s primary balance sheet. Investors care because these arrangements can hide risks, obligations or sources of cash flow that affect a company’s true financial strength and future performance.
Credit Agreement financial
"which amends the Credit Agreement, dated as of July 3, 2024, among the Company"
A credit agreement is a written loan contract between a borrower and a bank or other lender that lays out how much money can be borrowed, the interest rate, repayment schedule, fees, and the rules the borrower must follow. For investors, it matters because those terms affect a company’s cash costs, borrowing flexibility and risk of default — similar to how a mortgage’s rules determine a homeowner’s monthly budget and freedom to make changes.
L/C issuer financial
"Coöperatieve Rabobank U.A., New York Branch, as administrative agent, collateral agent and L/C issuer"
FAQ
What did Phibro Animal Health (PAHC) change in its credit agreement?
Phibro Animal Health (PAHC) signed Amendment No. 1 to its existing Credit Agreement. The amendment increases the company’s revolving credit commitment with Rabobank and other lenders, giving it access to a larger committed borrowing capacity under the same syndicated facility.
By how much did Phibro Animal Health (PAHC) increase its revolving credit facility?
Phibro Animal Health (PAHC) increased its revolving credit commitment by $125,000,000. The facility rose from $310,000,000 to a total aggregate commitment of $435,000,000 under Amendment No. 1 to the Credit Agreement dated April 28, 2026.
Who are the key parties to Phibro Animal Health’s (PAHC) amended Credit Agreement?
The key parties are Phibro Animal Health Corporation as borrower and Coöperatieve Rabobank U.A., New York Branch as administrative agent, collateral agent, and L/C issuer, along with the lenders party to the agreement, all operating under the amended Credit Agreement structure.
Why is the Phibro Animal Health (PAHC) credit amendment classified as a material definitive agreement?
It is classified as a material definitive agreement because it significantly amends a core financing contract. The amendment changes the revolving credit commitment to $435,000,000, creating a notable direct financial obligation for Phibro that is important enough to require current disclosure.
How does the amended credit facility affect Phibro Animal Health’s (PAHC) financial obligations?
The amendment increases Phibro Animal Health’s available revolving credit, which is reported as a direct financial obligation. While it expands borrowing capacity to $435,000,000, the actual balance sheet impact depends on how much of the facility the company chooses to draw over time.